What to make of FDA’s new JUUL Rule? Well, you could feel ‘hope’ after hearing Commissioner Scott Gottlieb state that there is a “public health benefit” for adult cigarette smokers who switch to vaping. Gottlieb also emphasized the importance of flavors for adult vapers and he clarified FDA “is not revisiting the compliance policy” for vapor products sold in age-restricted locations i.e. vape shops.
This sounds like great news, but is it?
It’s certainly not good news for JUUL or its millions of customers who now face the dreary prospect of lost access, to the products they rely on, to kick smoking or to stay quit. Ramifications could be dire says Dr. Michael Siegel from Boston University School of Public Health.
In this episode of RegWatch hear Dr. Siegal dismantle each of the most inflated, overwrought misperceptions of vaping and learn why he thinks FDA’s regulatory action against JUUL could have “devastating impacts on the public’s health.”
Only on RegWatch by RegulatorWatch.com
Produced by: Brent Stafford
Released: November 17, 2018